MedWatch

Three reasons to buy the Coloplast-share

Following a positive analysis of the Coloplast-share from the Bank of America, Danish bank Nordea has also offered an unambiguous recommendation of the Danish company based on three specific factors.

Foto: Jyllandsposten

This morning Nordea lends its support to the positive analysis issued by Bank of America late last week, and explains the recommendation with three specific factors.

“We could not agree more and see three reasons to purchase the share: 1) New strategy focused on merging markets, especially China 2) continued improvements of efficiency will help lift earnings and 3) debts have been paid off, paving the way for extraordinary dividend.”

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier